These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 26090888)

  • 61. Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy.
    Richard P; Isnard R; Carrier L; Dubourg O; Donatien Y; Mathieu B; Bonne G; Gary F; Charron P; Hagege M; Komajda M; Schwartz K; Hainque B
    J Med Genet; 1999 Jul; 36(7):542-5. PubMed ID: 10424815
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification of a novel hypertrophic cardiomyopathy-associated mutation using targeted next-generation sequencing.
    Zhao Y; Feng Y; Ding X; Dong S; Zhang H; Ding J; Xia X
    Int J Mol Med; 2017 Jul; 40(1):121-129. PubMed ID: 28498465
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [A novel hot-spot mutation S236G in the cardiac myosin binding protein C gene in Chinese patient with hypertrophic cardiomyopathy].
    Wang H; Song L; Zou YB; Wang JZ; Sun K; Gao S; Zhang CN; Hui RT
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Dec; 37(12):1078-80. PubMed ID: 20193176
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Short communication: the cardiac myosin binding protein C Arg502Trp mutation: a common cause of hypertrophic cardiomyopathy.
    Saltzman AJ; Mancini-DiNardo D; Li C; Chung WK; Ho CY; Hurst S; Wynn J; Care M; Hamilton RM; Seidman GW; Gorham J; McDonough B; Sparks E; Seidman JG; Seidman CE; Rehm HL
    Circ Res; 2010 May; 106(9):1549-52. PubMed ID: 20378854
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice.
    Fraysse B; Weinberger F; Bardswell SC; Cuello F; Vignier N; Geertz B; Starbatty J; Krämer E; Coirault C; Eschenhagen T; Kentish JC; Avkiran M; Carrier L
    J Mol Cell Cardiol; 2012 Jun; 52(6):1299-307. PubMed ID: 22465693
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Allelic imbalance and haploinsufficiency in MYBPC3-linked hypertrophic cardiomyopathy.
    Glazier AA; Thompson A; Day SM
    Pflugers Arch; 2019 May; 471(5):781-793. PubMed ID: 30456444
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gender- and age-related differences in distinct phenotypes of hypertrophic cardiomyopathy-associated mutation MYBPC3-E334K.
    Yang QL; Zuo L; Ma ZL; Lei CH; Zhu XL; Wang XY; Wang B; Zhao XL; Zhang J; Wang Y; Zhang YM; Liu LW
    Heart Vessels; 2021 Oct; 36(10):1525-1535. PubMed ID: 33830315
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Mutation and clinical relevance in a large cohort of unrelated Chinese patients with hypertrophic cardiomyopathy].
    Jie L; Wenling L; Dayi H; Tiangang Z; Wen L; Zhanfeng M; Jie Y; Wenli X; Cuilan L; Lei L; Guozhong P
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Aug; 43(8):682-9. PubMed ID: 26955724
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Compound heterozygosity deteriorates phenotypes of hypertrophic cardiomyopathy with founder MYBPC3 mutation: evidence from patients and zebrafish models.
    Hodatsu A; Konno T; Hayashi K; Funada A; Fujita T; Nagata Y; Fujino N; Kawashiri MA; Yamagishi M
    Am J Physiol Heart Circ Physiol; 2014 Dec; 307(11):H1594-604. PubMed ID: 25281569
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Genetic basis of end-stage hypertrophic cardiomyopathy.
    Garcia-Pavia P; Vázquez ME; Segovia J; Salas C; Avellana P; Gómez-Bueno M; Vilches C; Gallardo ME; Garesse R; Molano J; Bornstein B; Alonso-Pulpon L
    Eur J Heart Fail; 2011 Nov; 13(11):1193-201. PubMed ID: 21896538
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gender differences in the clinical features of hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations.
    Terauchi Y; Kubo T; Baba Y; Hirota T; Tanioka K; Yamasaki N; Furuno T; Kitaoka H
    J Cardiol; 2015 May; 65(5):423-8. PubMed ID: 25123604
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A human MYBPC3 mutation appearing about 10 centuries ago results in a hypertrophic cardiomyopathy with delayed onset, moderate evolution but with a risk of sudden death.
    Teirlinck CH; Senni F; Malti RE; Majoor-Krakauer D; Fellmann F; Millat G; André-Fouët X; Pernot F; Stumpf M; Boutarin J; Bouvagnet P
    BMC Med Genet; 2012 Nov; 13():105. PubMed ID: 23140321
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Genotype-Phenotype Correlations in Apical Variant Hypertrophic Cardiomyopathy.
    Towe EC; Bos JM; Ommen SR; Gersh BJ; Ackerman MJ
    Congenit Heart Dis; 2015; 10(3):E139-45. PubMed ID: 25495007
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The R820W mutation in the MYBPC3 gene, associated with hypertrophic cardiomyopathy in cats, causes hypertrophic cardiomyopathy and left ventricular non-compaction in humans.
    Ripoll Vera T; Monserrat Iglesias L; Hermida Prieto M; Ortiz M; Rodriguez Garcia I; Govea Callizo N; Gómez Navarro C; Rosell Andreo J; Gámez Martínez JM; Pons Lladó G; Cremer Luengos D; Torres Marqués J
    Int J Cardiol; 2010 Nov; 145(2):405-407. PubMed ID: 20542340
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Rapid detection of genetic variants in hypertrophic cardiomyopathy by custom DNA resequencing array in clinical practice.
    Fokstuen S; Munoz A; Melacini P; Iliceto S; Perrot A; Ozcelik C; Jeanrenaud X; Rieubland C; Farr M; Faber L; Sigwart U; Mach F; Lerch R; Antonarakis SE; Blouin JL
    J Med Genet; 2011 Aug; 48(8):572-6. PubMed ID: 21239446
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy.
    Rodríguez-García MI; Monserrat L; Ortiz M; Fernández X; Cazón L; Núñez L; Barriales-Villa R; Maneiro E; Veira E; Castro-Beiras A; Hermida-Prieto M
    BMC Med Genet; 2010 Apr; 11():67. PubMed ID: 20433692
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hypertrophic cardiomyopathy-linked variants of cardiac myosin-binding protein C3 display altered molecular properties and actin interaction.
    Da'as SI; Fakhro K; Thanassoulas A; Krishnamoorthy N; Saleh A; Calver BL; Safieh-Garabedian B; Toft E; Nounesis G; Lai FA; Nomikos M
    Biochem J; 2018 Dec; 475(24):3933-3948. PubMed ID: 30446606
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Founder mutation in myosin-binding protein C with an early onset and a high penetrance in males.
    Méndez I; Fernández AI; Espinosa MÁ; Cuenca S; Lorca R; Rodríguez JF; Tamargo M; García-Montero M; Gómez C; Vilches S; Vázquez N; Álvarez R; Medrano C; Yotti R; Fernández-Avilés F; Bermejo J
    Open Heart; 2021 Sep; 8(2):. PubMed ID: 34588271
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy.
    Meurs KM; Sanchez X; David RM; Bowles NE; Towbin JA; Reiser PJ; Kittleson JA; Munro MJ; Dryburgh K; Macdonald KA; Kittleson MD
    Hum Mol Genet; 2005 Dec; 14(23):3587-93. PubMed ID: 16236761
    [TBL] [Abstract][Full Text] [Related]  

  • 80. First identification of homozygous truncating CSRP3 variants in two unrelated cases with hypertrophic cardiomyopathy.
    Janin A; Bessière F; Chauveau S; Chevalier P; Millat G
    Gene; 2018 Nov; 676():110-116. PubMed ID: 30012424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.